Skip to content
Clinical Trials – home

INSULIN HUMAN: A Comprehensive Guide for Patients

3 / 7
trials open to patients / all trials
7+
Countries

In short

This article examines several clinical trials investigating the use of human insulin in managing diabetes. These studies aim to evaluate the effectiveness, safety, and pharmacodynamic properties of various insulin formulations and administration methods. The trials focus on different aspects of insulin therapy, including its use in type 1 and type 2 diabetes, perioperative glucose management, and comparisons between different insulin types and delivery methods.

At a glance

Types of Diabetes Studied
Type 1 and Type 2 diabetes
Insulin Formulations
Regular human insulin, insulin lispro, premixed insulins, basal insulins, rapid-acting insulins, VIAject
Administration Methods
Subcutaneous injections, intravenous infusions, basal-bolus regimens, premixed regimens
Key Outcome Measures
Blood glucose levels, HbA1c, hypoglycemic events, insulin sensitivity, post-meal glucose control
Special Populations
Patients with end-stage renal disease, perioperative patients
Novel Approaches
Comparison of insulin types, evaluation of educational interventions, assessment of glucose monitoring techniques

What is Insulin Human?

Insulin Human is a medication used to manage blood sugar levels in people with diabetes. It is a synthetic version of the insulin naturally produced by the human body. Insulin Human is also known by other names such as regular human insulin or Humulin R. This medication helps your body use glucose (sugar) for energy and prevents your blood sugar from getting too high.

Uses and Conditions Treated

Insulin Human is primarily used to treat Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus. These are conditions where your body either doesn't produce enough insulin (Type 1) or doesn't use insulin effectively (Type 2), leading to high blood sugar levels. By using Insulin Human, patients can better control their blood sugar levels and manage their diabetes.

Types and Formulations

Insulin Human comes in different types and formulations to suit various patient needs:

  • Regular Human Insulin: This is a short-acting insulin that starts working quickly after injection.
  • Non-preserved (NP) formulation: A special form of regular human insulin that may be combined with other substances to enhance its effectiveness.
  • Premixed Insulin: A combination of different types of insulin in one injection, which can provide both immediate and longer-lasting blood sugar control.

Administration and Dosing

Insulin Human is typically administered through subcutaneous (under the skin) injections. The dosing and frequency can vary depending on the specific formulation and individual patient needs:

  • Regular Human Insulin: Often injected before meals to control blood sugar spikes after eating.
  • Premixed Insulin: May be given once or twice daily, usually before breakfast and dinner.
  • Implantable Insulin: In some cases, Insulin Human may be administered through an implantable pump system for continuous delivery.

The exact dosing is determined by your healthcare provider based on factors such as your blood sugar levels, weight, and lifestyle.

Effectiveness and Benefits

Insulin Human has been shown to be effective in managing blood sugar levels in people with diabetes. Some of the key benefits include:

  • Improved Glycemic Control: Helps achieve target HbA1c levels (a measure of average blood sugar over 2-3 months).
  • Flexibility: Different formulations allow for tailored treatment plans to suit individual needs.
  • Reduced Complications: Proper use can help prevent or delay diabetes-related complications by maintaining good blood sugar control.

Safety and Side Effects

While Insulin Human is generally safe and effective when used as prescribed, it can have some side effects:

  • Hypoglycemia: Low blood sugar is the most common side effect. Symptoms can include shakiness, sweating, confusion, and in severe cases, loss of consciousness.
  • Weight Gain: Some patients may experience weight gain when starting insulin therapy.
  • Injection Site Reactions: Redness, swelling, or itching at the injection site can occur.

It's important to monitor your blood sugar levels regularly and follow your healthcare provider's instructions carefully to minimize these risks.

Comparisons with Other Insulins

Insulin Human is often compared to other types of insulin in clinical studies:

  • Insulin Glargine: A long-acting insulin that may provide more stable blood sugar control over 24 hours compared to regular human insulin.
  • Insulin Lispro: A rapid-acting insulin that may work more quickly than regular human insulin.
  • Insulin Degludec: An ultra-long-acting insulin that may offer more flexibility in dosing time compared to regular human insulin.

Your healthcare provider will consider various factors when choosing the best insulin regimen for you, including your lifestyle, blood sugar patterns, and personal preferences.

Questions people often ask

Conditions where Insulin Human is being studied

Each condition opens its own overview and trial list

Trials with Insulin Human

Recruiting trials first

See all 7 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).